A phase II trial of Down staging Chemotherapy with Nab-paclitaxel plus Gemcitabine in patients with locally advanced pancreatic cancer
Latest Information Update: 09 Apr 2020
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary) ; Gimeracil/oteracil/tegafur
- Indications Ductal carcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms CAP-005
- 08 Apr 2020 Status changed from recruiting to active, no longer recruiting.
- 10 May 2017 Status changed from not yet recruiting to recruiting.
- 25 May 2016 New trial record